Company
Numerion Labs
Description
Builds an AI platform that searches chemical space for novel drug-like molecules, supporting small-molecule drug discovery programs for immune and inflammatory diseases.
Related
Genesis TherapeuticsBuilds molecular AI models and a design platform to optimize small-molecule drug discovery and create new medicines for partners and…
Verge GenomicsBuilds AI models and discovery tools using multimodal human CNS data to identify drug targets, match patients, and support neurological…
Isomorphic LabsBuilds predictive and generative AI models for drug discovery, used to accelerate scientific discovery and design novel molecules for…
Ditto BiosciencesDiscovers drug candidates by using parasite biology and AI to identify parasite proteins that could treat autoimmune diseases driven by an…
OpenEvidenceSearches medical knowledge with AI. Also: Biotech.
WonderTxApplies extrapolative AI to drug discovery research, aiming to identify new drugs and investigate oral pill alternatives to injectable…
Xaira TherapeuticsBuilds an AI-powered drug discovery and development platform to decode disease, design therapies, and support end-to-end medicine creation…
Curia (formerly AMRI)Provides CDMO services for drug discovery, development, and manufacturing, supporting pharmaceutical clients with small molecules, generic…
Atomic AIBuilds RNA foundation models and wet-lab assays to predict RNA structure and function, supporting discovery of RNA-targeted small molecules…
Schrödinger ($SDGR)Develops a physics-based computational platform to discover, optimize, and formulate molecules and materials for drug discovery teams and…
Locus BiosciencesDevelops bacteriophage-based precision medicines and microbiome biotherapeutics to target disease-causing bacteria in infections, with…
IktosIktos develops an AI-driven platform for drug discovery. It supports molecule design, retrosynthesis, robotic synthesis, analysis, testing,…